Allergy Testing and Diagnosis
RAST Test
Measures IgE levels after exposure to allergen
Very high false positive rate (50% of IgE inhalants and 40-80% for peanut
extracts)
Can be anaphylactic to brazil nuts but have negative IgE test
Positive IgE test doesn’t mean the patient will ever have a reaction
Allergy Skin Prick/Scratch Test/Intradermal Allergy Test
Small amount of allergen introduced under the skin
Positive will have vasodilation and oedema as mast cells react
Symptoms – redness, itchiness and swelling
Histamine
Synthesis – decarboxylation of His by Histidine decarboxylase
Stored at sight of synthesis
Concentrated in lungs, GIT and skin
IgE-R:
Type 1 – targets mast cells and basophils, high IgE affinity and mediated by
histamine, leukotrienes, bradykinin and prostaglandins
Type 2 – targets lymphocytes, platelets, eosinophils and monocytes, low affinity
for IgE and mediated by chemokines, IgE binding factor, mitogens and
inflammatory mediators
Histamine Receptors:
H1, H2, H3 and H4
All GPCRs
H1 – smooth muscle contraction, vasodilation, increased vascular permeability
and increased secretion
H2 – stimulate GI secretion and cardiac stimulation
H3 – CNS effects
Inhibitors:
Release inhibitors – mast cell stabilisers (Cromolyn and Nedocromil) and beta 2
agonists
Histamine receptor antagonists
RAST Test
Measures IgE levels after exposure to allergen
Very high false positive rate (50% of IgE inhalants and 40-80% for peanut
extracts)
Can be anaphylactic to brazil nuts but have negative IgE test
Positive IgE test doesn’t mean the patient will ever have a reaction
Allergy Skin Prick/Scratch Test/Intradermal Allergy Test
Small amount of allergen introduced under the skin
Positive will have vasodilation and oedema as mast cells react
Symptoms – redness, itchiness and swelling
Histamine
Synthesis – decarboxylation of His by Histidine decarboxylase
Stored at sight of synthesis
Concentrated in lungs, GIT and skin
IgE-R:
Type 1 – targets mast cells and basophils, high IgE affinity and mediated by
histamine, leukotrienes, bradykinin and prostaglandins
Type 2 – targets lymphocytes, platelets, eosinophils and monocytes, low affinity
for IgE and mediated by chemokines, IgE binding factor, mitogens and
inflammatory mediators
Histamine Receptors:
H1, H2, H3 and H4
All GPCRs
H1 – smooth muscle contraction, vasodilation, increased vascular permeability
and increased secretion
H2 – stimulate GI secretion and cardiac stimulation
H3 – CNS effects
Inhibitors:
Release inhibitors – mast cell stabilisers (Cromolyn and Nedocromil) and beta 2
agonists
Histamine receptor antagonists